About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The goal of the Shock, Organic Dysfunction and Resuscitation Research Group (SODIR) is comprehensive, innovative research into the areas of shock, acute respiratory failure, acute kidney failure, organic dysfunction, resuscitation and critical patient monitoring. In addition, the research group has a special interest in applying artificial intelligence as an instrument to find innovative solutions for critical patients.
PMID: 34048985 Journal: Translational Research Year: 2021 Reference: Transl Res. 2021 Oct;236:147-159. doi: 10.1016/j.trsl.2021.05.004. Epub 2021 May 26. Impact factor: 7.012 Publication type: Paper in international publication Authors: Gomez, Jose Manuel, Gonzalez-Rivera, Milagros, Micheloud, Dariela, Ryan, Pablo, Martinez, Amalia, Tamayo, Luis, Aldecoa, Cesar, Ferrer, Ricard, Ceccato, Adrian, Fernandez-Barat, Laia et al. DOI: 10.1016/j.trsl.2021.05.004
PMID: 34021318 Journal: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY Year: 2021 Reference: Eur J Cardiothorac Surg. 2021 Dec 1;60(6):1308-1315. doi: 10.1093/ejcts/ezab234. Impact factor: 4.191 Publication type: Paper in international publication Authors: Montoya, Pilar, Bello, Irene, Ascanio, Fernando, Romero, Laura, Perez, Javier, Rosado, Joel, Sanchez, Leire, Sacanell, Judith, Ribas, Montserrat, Berastegui, Cristina et al. DOI: 10.1093/ejcts/ezab234
PMID: 34011842 Journal: CRITICAL CARE MEDICINE Year: 2021 Reference: Crit Care Med. 2021 Jun 1;49(6):e660-e661. doi: 10.1097/CCM.0000000000004997. Impact factor: 7.598 Publication type: Letter or abstract Authors: Plata-Menchaca, Erika P, Ferrer, Ricard et al. DOI: 10.1097/CCM.0000000000004997
PMID: 33992168 Journal: JOURNAL OF CLINICAL NEUROSCIENCE Year: 2021 Reference: J Clin Neurosci. 2021 Jun;88:108-112. doi: 10.1016/j.jocn.2021.03.028. Epub 2021 Mar 23. Impact factor: 1.961 Publication type: Paper in international publication Authors: Chen, Austin, Requena, Manuel, Rubiera, Marta, Sanchez, Anna, Siegler, James E, Muchada, Marian, Lallana, Sofia et al. DOI: 10.1016/j.jocn.2021.03.028
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.
Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.
